The North America AI in clinical trials market, valued at USD 0.80 billion in 2025, is projected to reach USD 0.91 billion in 2026 and USD 2.58 billion by 2035, with a CAGR of 12.4% during the forecast period, 2026 to 2035. Based on the deployment mode, cloud-based AI solutions capture the largest share of the current market, and the trend is unlikely to change in the future.

The Europe AI in clinical trials market, valued at USD 0.90 billion in 2025, is projected to reach USD 1.01 billion in 2026 and USD 2.76 billion by 2035, with a CAGR of 11.8% during the forecast period, 2026 to 2035. In June 2026, Owkin entered a multiyear collaboration with Sanofi to build K Pro biopharma AI agents backed by a five-year K Pro license. K Pro uses multimodal patient data and agentic AI to support decisions from early discovery through clinical development. In April 2026, Boehring...

The global computational pathology market is expected to rise from USD 0.78 billion in 2026 to reach USD 2.46 billion by 2040, growing at a CAGR of 8.6% over the forecast period 2026 to 2040, driven by AI-enabled precision diagnostics and scalable digital workflows. Based on therapeutic area, oncology is both the dominant and fastest-growing category, holding 54.0% share in 2026 and expanding at 9.1% CAGR through 2040, driven by companion-diagnostic adoption. Based on end user, hospitals capture...

The Asia-Pacific AI in clinical trials market, valued at USD 1.40 billion in 2025, is projected to reach USD 1.61 billion in 2026 and USD 5.07 billion by 2035, with a CAGR of 13.6% during the forecast period, from 2026 to 2035. For instance, in March 2025, AstraZeneca invested USD 2.5 billion in a new strategic R&D center in Beijing, supported by an AI and data science laboratory, designed to advance early-stage research and clinical development. In June 2026, HistoIndex and D&D Pharmatech annou...

The global electronic health records market, valued at USD 41 billion in 2025, is projected to reach USD 45 billion in 2026 and USD 92 billion by 2035, representing a CAGR of 8.3% during the forecast period from 2026 to 2035. Healthcare delivery is becoming increasingly data-driven, and electronic health records (EHR) have emerged as the digital backbone of this transformation. Modern EHR platforms are no longer limited to replacing paper charts; they serve as centralized clinical information sy...

The global Smart Hospitals market is expected to rise from USD 15 billion in 2026 to reach USD 160 billion by 2040, growing at a CAGR of 18.4% over the forecast period 2026 to 2040, driven by rise in connected inpatient-room modernization. Based on technology / integration layer, EHR-integrated room systems capture 24.0% market share in 2026, whereas AI and computer vision analytics register a 24.4% CAGR through 2040, driven by real-time sensing and autonomous clinical documentation. Based on ap...

The North America pharma cloud services market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 21.2 billion by 2035, representing a CAGR of 13.5% during the forecast period from 2026 to 2035. Pharmaceutical companies in North America are increasingly adopting AI-enabled cloud platforms to accelerate drug discovery, clinical development, regulatory documentation, manufacturing, and commercial operations. As pharma companies handle large volumes of genomic...

The global healthcare interoperability solutions market is expected to rise from USD 5.8 billion in 2026 to reach USD 31.5 billion by 2040, growing at a CAGR of 12.8% over the forecast period 2026 to 2040, driven by regulatory interoperability mandates and cloud-native FHIR adoption. Long-term growth will accelerate as cloud deployment, semantic interoperability, and FHIR APIs reshape procurement through 2040. Oracle Health received TEFCA QHIN designation in November 2025 and linked customer onb...

The global digital phenotyping market is expected to rise from USD 2.0 billion in 2026 and is projected to reach USD 7.1 billion by 2040, growing at a CAGR of 9.5% over the forecast period 2026 to 2040, driven by regulated remote digital endpoints and AI-enabled multimodal capacity monitoring. Based on Geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 12.4% CAGR through 2040, driven by healthcare digitalization and trial localization.

The global eConsent in healthcare market is expected to rise from USD 0.62 billion in 2026 and is projected to reach USD 2.48 billion by 2040, growing at a CAGR of 10.4% over the forecast period 2026 to 2040, driven by clinical-trial digitalization, remote consent workflows, and regulated patient-data sharing. Based on platform / deployment model, cloud-based platforms capture 70.0% market share in 2026, whereas hybrid deployments register an 18.8% CAGR through 2040, driven by mixed site-and-rem...

The global cloud based drug discovery platforms market, valued at USD 3.7 billion in 2025, is projected to reach USD 4.2 billion in 2026 and USD 11.4 billion by 2035, representing a CAGR of 11.7% during the forecast period 2026 to 2035. Cloud based drug discovery platforms are centralized, internet-hosted software ecosystems that provide scalable computing power, data storage, and advanced analytics tools to accelerate the discovery of new therapeutic compounds. According to our projections, Nor...

The global hospital command center market is expected to rise from USD 2.40 billion in 2026 to reach USD 10.10 billion by 2040, growing at a CAGR of 10.8% over the forecast period 2026 to 2040, driven by hospital-wide demand for real-time capacity orchestration. Based on Geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 13.5% CAGR through 2040, supported by digital hospital infrastructure expansion.

The global AI in clinical trials market, valued at USD 3.48 billion in 2025, is projected to reach USD 3.96 billion in 2026 and USD 11.61 billion by 2035, representing a CAGR of 12.7% during the forecast period 2026 to 2035. Based on the deployment mode, cloud-based AI solutions capture the largest share (around 75%) of the current market, and the trend is unlikely to change in the future. In terms of therapeutic areas, oncological disorders are expected to hold the largest market share (more th...

The global hospital at home market reached USD 29.0 billion in 2026 and is projected to reach USD 199.1 billion by 2040, growing at a CAGR of 14.8% over the forecast period 2026 to 2040, driven by hospital capacity constraints. Based on geography, North America captures 46.0% market share in 2026, whereas Asia-Pacific registers a 17.3% CAGR through 2040, driven by virtual hospital scale-up. Based on component / offering, Services capture 54.0% market share in 2026, whereas Software platforms reg...

The global big data in healthcare market, valued at USD 93 billion in 2025, is projected to reach USD 110 billion in 2026 and USD 540 billion by 2035, with a 19.37% CAGR during the forecast period 2026 to 2035. The geographical regions segment highlights the distribution of big data in healthcare market across various geographies, such as North America, Europe, Asia, Latin America, Middle East and North Africa, and rest of the world regions. According to our projections, the big data analytic...

The global pediatric telehealth market is expected to rise from USD 58.0 billion in 2026 to reach USD 445.7 billion by 2040, growing at a CAGR of 15.7% over the forecast period 2026 to 2040, driven by rising child-focused virtual access, behavioral health demand and remote monitoring adoption. Based on Offering, Services capture 55.0% market share in 2026, whereas Software registers a 17.5% CAGR through 2040, driven by AI-enabled workflow expansion. Based on Delivery / Interaction Mode, Audiovis...

The global climate tech market is expected to rise from USD 46.5 billion in 2026 and is projected to reach USD 691.4 billion by 2040, growing at a CAGR of 21.3% over the forecast period 2026 to 2040, driven by electrification and industrial decarbonization. Current growth comes from electrification, grid modernization, corporate procurement, and policy-backed infrastructure financing. Germany’s government planned EUR 13.3 billion in 2027 energy-cost relief during July 2026, including grid-fee...

The global teleradiology services market, valued at USD 9.2 billion in 2025, is projected to reach USD 10.1 billion in 2026 and USD 23.3 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of imaging modality, CT scan accounted for 35% of market revenues in 2026.With respect to end user, hospitals (51%) dominate the current market.

The global healthcare LLMOps market is expected to rise from USD 1.25 billion in 2026 to reach USD 22.40 billion by 2040, growing at a CAGR of 22.9% over the forecast period 2026 to 2040, driven by governed clinical AI workflows and agentic automation. Based on Deployment Mode, Public cloud deployment captures 49.0% market share in 2026, whereas Hybrid cloud deployment registers a 25.0% CAGR through 2040, as regulated workloads balance hyperscale AI with local controls. Based on Application / Us...

The global clinical trial simulation market is expected to rise from USD 4.2 billion in 2026 to reach USD 11.8 billion by 2040, growing at a CAGR of 7.7% over the forecast period 2026 to 2040, driven by regulatory acceptance and AI-generated virtual patients. Based on application, dose and dosing-regimen optimization captures 24.0% market share in 2026, whereas synthetic or external control generation registers an 11.9% CAGR through 2040, supported by smaller trial cohorts. Based on end user, ph...